1.
Papp K, Reich K, Blauvelt A, Thaci D, Sinclair R, Tyring SK, Cichanowitz N, Green S, Li Q, La Rosa C. Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S4. Available from: https://jofskin.org/index.php/skin/article/view/252